... was told I would be under general anesthesia for the entire procedure and would wake up in the recovery area
Hitchhiker, you might want to double check on this. For my procedure (as well as all others that I have heard about
), I was under general anesthesia only for the insertion of the tubes. During the radiation and for tube removal, I was awake. Since I had 3 radiation fractions each session, I was in the hospital bed with the tubes inserted (and not under general) for about
24 hours each session. If you are going to have multiple fractions, I don't think they would keep you under general anesthesia the whole time.
If you are going to be awake for some of the time, check to see if you will have a push button for dosing yourself with morphine (or the synthetic equivalent). If so, you will want to have a watch accessible. The push button has a timer, so it will only dose you every 5 minutes or so. I was maxing out on the push button each time they re-positioned the tubes before each fraction. Also, as previously stated, it hurts when they pull the tubes, but only for a few seconds. I maxed out the dosage for that as well.HG,
Thanks for the info, I will give the RN for my RO a call tomorrow to get clarity. IIRC, the urologist that will be performing the cystoscopy during my procedure said total time I would be under anesthesia would be about
three hours. The way FCCC is set up, I never leave the treatment room, one stop shopping. I took that to mean I'd be out for those three hours, during which I will receive two fractions of HDR radiation.
I had read the HDR BT procedural descript
ion that is out on the UCLA site which had verbiage about
having the catheters in while awake and having a push button dosing option. I specifically expressed concern about
this approach during my meeting with my urologist, and came away thinking this wasn't the case at FCCC, but I will get clear verification tomorrow and post back once I know for sure. Again, I'm somewhat of a wuss when it comes to pain.
Diagnosed at 42, 11/13, PSA 5.8, DRE negative, GS 6, 1 of 12 cores positive, <5%. MRI guided biopsy at Johns Hopkins. Active surveillance chosen.
NIH T3 endo-rectal MRI 11/14, PSA 6.5, fusion MRI guided biopsy 5/15. 6/18 cores positive for G6. DRE negative.
Consults at NIH, JH, Penn, FCCC (Fox Chase). Scheduled for HDR BT monotherapy at FCCC 2.17.2016 & 2.24.2016.